In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Glyceroli trinitratis Drug Master File in Korea (Glyceroli trinitratis KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Glyceroli trinitratis. The MFDS reviews the Glyceroli trinitratis KDMF as part of the drug registration process and uses the information provided in the Glyceroli trinitratis KDMF to evaluate the safety and efficacy of the drug.
After submitting a Glyceroli trinitratis KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Glyceroli trinitratis API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Glyceroli trinitratis suppliers with KDMF on PharmaCompass.